{"project/01 immunogenic chemotherapy/202209271124_oxcy-project-5.md":{"scroll":21.7991,"cursor":{"from":{"ch":0,"line":22},"to":{"ch":0,"line":22}}},"project/01 immunogenic chemotherapy/202209271048_oxcy-project-4.md":{"scroll":0,"cursor":{"from":{"ch":25,"line":2},"to":{"ch":25,"line":2}}},"daily/2022-10-10.md":{"scroll":0,"cursor":{"from":{"ch":54,"line":7},"to":{"ch":54,"line":7}}},"project/01 immunogenic chemotherapy/overview_project01.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":16},"to":{"ch":0,"line":16}}},"todo.md":{"scroll":0,"cursor":{"from":{"ch":42,"line":8},"to":{"ch":42,"line":8}}},"marker_ly6g.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":12},"to":{"ch":0,"line":12}}},"cell_monocyte.md":{"scroll":0,"cursor":{"from":{"ch":2,"line":11},"to":{"ch":2,"line":11}}},"cell_dendritic.md":{"scroll":0,"cursor":{"from":{"ch":113,"line":12},"to":{"ch":113,"line":12}}},"cell_cytotoxic-t.md":{"scroll":2.5232,"cursor":{"from":{"ch":11,"line":12},"to":{"ch":11,"line":12}}},"panel_murine-hybrid-survey-01.md":{"scroll":0,"cursor":{"from":{"ch":12,"line":22},"to":{"ch":12,"line":22}}},"logs/2022-10-10 Barnado Lab Meeting.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":0},"to":{"ch":0,"line":0}}},"logs/2022-10-03 Tseng Lab Meeting.md":{"scroll":0,"cursor":{"from":{"ch":0,"line":0},"to":{"ch":0,"line":0}}},"logs/2022-10-03 Barnado Lab Meeting.md":{"scroll":0,"cursor":{"from":{"ch":14,"line":10},"to":{"ch":14,"line":10}}},"logs/2022-20-11 HVTN 307 Protocol Notes.md":{"scroll":0,"cursor":{"from":{"ch":86,"line":8},"to":{"ch":86,"line":8}}},"daily/2022-10-11.md":{"scroll":0,"cursor":{"from":{"ch":117,"line":9},"to":{"ch":117,"line":9}}},"daily/2022-10-12.md":{"scroll":0,"cursor":{"from":{"ch":20,"line":19},"to":{"ch":20,"line":19}}},"logs/2022-10-17_0904 Barnado Lab Meeting.md":{"scroll":0,"cursor":{"from":{"ch":38,"line":10},"to":{"ch":38,"line":10}}}}